Cannabidiol
| CBD | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 314.50 g/mol [1] |
| Predicted LogP | 6.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C21H30O2 |
| IUPAC name | 2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol |
| SMILES | CCCCCC1=CC(=C(C(=C1)O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O |
| InChI | InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1 |
| InChIKey | QHMBSVQNZZTUGM-ZWKOTPCHSA-N |
| CAS number | 13956-29-1 |
| UNII | 19GBJ60SN5 |
| PubChem CID | 644019 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 18–32 hours[3] |
| Routes of administration | By mouth, sublingual, buccal, inhalation[4][5] |
| Addiction liability | None[6] |
Cannabidiol (also known as (-)-Cannabidiol, (-)-trans-Cannabidiol, Epidiolex, Δ1(2)-trans-Cannabidiol, Gwp42003-p, cannabidiolum, Cardiolrx, (-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol, NanoCDB or Melody Cloverstrip) is a cannabinoid and opioid substance of the phenol and benzochromene class.
Chemistry
Stereochemistry []
Cannabidiol is a single defined stereoisomer (optical activity ( - )).
Druglikeness
Lipinski's rule of five
Cannabidiol matches Lipinski's rule of five (violations: 1).Reagents
There are currently 12 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | dark brown > black | |
| Mecke | dark brown > black | |
| Mandelin | dark brown > black | |
| Liebermann | orange > brown | |
| Froehde | brown | |
| Robadope | no pink color change | |
| Simon's | no blue color change | |
| Ehrlich | purple | |
| Hofmann | orange | |
| Morris | pale green | |
| Zimmermann | fast purple | |
| Cannabis (4-AP) | pink / purple |
Pharmacology
ATC Classification
- nervous system (N)
- antiepileptics (N03)
- antiepileptics (N03A)
- other antiepileptics (N03AX)
- cannabidiol (N03AX24)
MeSH Classification
- anticonvulsants (M0001382)
Mechanism of action []
The exact mechanism of action of CBD and THC is not currently fully understood. However, it is known that CBD acts on cannabinoid (CB) receptors of the endocannabinoid system, which are found in numerous areas of the body, including the peripheral and central nervous systems, including the brain. The endocannabinoid system regulates many physiological responses of the body including pain, memory, appetite, and mood. More specifically, CB1 receptors can be found within the pain pathways of the brain and spinal cord where they may affect CBD-induced analgesia and anxiolysis, and CB2 receptors have an effect on immune cells, where they may affect CBD-induced anti-inflammatory processes. CBD has been shown to act as a negative allosteric modulator of the cannabinoid CB1 receptor, the most abundant G-Protein Coupled Receptor (GPCR) in the body. Allosteric regulation of a receptor is achieved through the modulation of the activity of a receptor on a functionally distinct site from the agonist or antagonist binding site. The negative allosteric modulatory effects of CBD are therapeutically important as direct agonists are limited by their psychomimetic effects while direct antagonists are limited by their depressant effects. [1]
Interactions []
Subjective effects []
Experience reports
Erowid
There are currently 17 experience reports involving cannabidiol on Erowid: []- "Managing Anxiety" by Whimsy
- "Something Telling Me That I Can't Forget the Trip" by RB
- "The Chill Candy" by Random Output
- "Helps Immensely with Panic Attacks and Insomnia" by dadweed
- "Electromechanical Forced Vocal Skull Intrusion" by bindingaffinity
- "Unexpected, Wonderful" by Martin
- "Sleep Aid for Student Stress" by lil vincent millay
- "Discern" by Flex
- "Makes Life More Enjoyable" by Chronic Man
- "Feelings of Relaxation" by MedHelper
- "Double-Blind Experiment" by mustpayby
- "Purple/Yellow Tinted Vision/Spine Shock Tingle" by YamahaJunky420
- "A Warm Sense of Calm" by CBDman22
- "Cannahoney" by Drugdandy
- "Incredible Feeling Just Awesome" by Wishing_Well
- "Incredible Feeling Just Awesome" by Wishing_Well
- "Bringing the Pintocin to the Party" by Research Scientist
- "Doing Every Drug For The Last Time" by stjakey (39 upvotes)
- "Salvia, DXM, Nitrous and Tobacco: Became a salvia god" by [deleted] (35 upvotes)
- "THC-O Trip Report" by Drewmydudes (24 upvotes)
- "1000 mcg trip report" by SFwandering2day (22 upvotes)
- "First ever trip, very intense and full report, please someone read!:)" by pastel_pixie37 (21 upvotes)
- "God dissipated me into nothingness (3 grams ABV, 2 grams kratom, 2 tabs)" by RicC137-2 (20 upvotes)
- "My first Edibles Brain-melt experience + 'Enlightened' Ramblings in an Excel Spreadsheet" by Stabinob (15 upvotes)
- "10mg THC and 60mg CBD Report" by MoneyBuysHapiness (15 upvotes)
- "120 HBWR and a 100 mg edible" by throwawayaccount8279 (14 upvotes)
- "The truth about psychedelics (Mushroom Trip Report)" by LongTimeToker91 (13 upvotes)
- "4g of Golden Teachers" by KronixPC (12 upvotes)
- "5ish gram Cambodian Cubensis report" by MrMooman9 (12 upvotes)
- "10 hits first time lightweight on a pen" by reddit_detective_ (11 upvotes)
- "2gs Golden Teachers and 72mg 5-MAPB + hordenine: Incredibly healing and profoundly blissful experience" by COVID19_In_My_ANUS (9 upvotes)
- "[4-AcO-MET, 40mg] Your Brain has Crashed" by space_cadet_mkultra (8 upvotes)
- "Terrifying, humorous, and just plain weird shrooms experience:" by LazyDaisy85 (7 upvotes)
- "first time meeting an online friend u already know we got high as hell" by HistoricalNebula5050 (6 upvotes)
- "Mushroom trip report" by [deleted] (5 upvotes)
- "My 100% federally legal 4 Day Plateau 1 Tour Guid/Trip Report" by Azzanadra_ (5 upvotes)
- "First time tripping on shrooms" by Shroomer14 (5 upvotes)
- "did weed for the first time after bad shroom trip" by brokenflushtoilet (5 upvotes)
- "Could there be a deeper meaning to my 60x salvia trip?" by Tripzy805 (5 upvotes)
- "MAL+FXE trip report" by lowkey_add1ct (4 upvotes)
- "What was in that gummy? A "cannabis oil" trip report" by nils_olav_III (4 upvotes)
- "2.5g Cubensis psilocybin mushroom trip" by Frances_Herbert (3 upvotes)
- "Ok So CINAZEPAM AND THC IS LOVELY" by esganjia (3 upvotes)
- "Sublingual Experiment - DXM, DELTA-8 THC, ALCOHOL" by cmdr_bxs (3 upvotes)
- "high dose mirtazapine (remeron) 210mg" by buncedback (3 upvotes)
- "Edibles scared me. Please help." by Key_Ad_7766 (2 upvotes)
- "Out of body experience and hallucinations on weed" by keepingitupco (2 upvotes)
- "Pretty Intense" by ZeusStinkhammer (2 upvotes)
- "Long time lurker." by cmdr_bxs (2 upvotes)
- "pain reduction during mushroom trip...anyone else?" by Public_Ad325 (1 upvotes)
- "What was in that gummy? Re-written by ChatGPT in the style of a Terrence McKenna trip report" by nils_olav_III (1 upvotes)
- "Vaccination anxiety relief and a psychonautical "study"" by PurveyorOfCacti (1 upvotes)
- "CBDX/CANNABIDIOL EGO DEATH/TRIP???" by musminino (1 upvotes)
- "I had a really strange trip with weed" by No-Rub-8070 (1 upvotes)
- "1mg of 4-ho-met for a hypersensitive individual." by OutrageousBag1778 (1 upvotes)
- "Agmatine Sulfate + Magnesium + Alcohol + Cannabis" by gennextco (1 upvotes)
Legal status []
- Australia: Cannabidiol is a Schedule 4.
- Brazil: Cannabidiol is a Synthetic: C3; Oil with <0,2% THC: B1; Oil <30mg/ml THC and <30mg/ml CBD: A3.[7]
- Canada: Cannabidiol is Unscheduled.
- Germany: Cannabidiol is a Anlage III under the "Betäubungsmittelgesetz (BtMG)".
- New Zealand: Cannabidiol is Unscheduled.
- United Kingdom: Cannabidiol is a GSL.
- United States: Cannabidiol is Prescription only as Epidiolex; Unscheduled if derived from hemp with <0.3% Δ<sup>9</sup>-THC, Schedule III if derived from cannabis with >0.3% THC when dispensed from a state-licensed medical dispensary.[8][9][10]
- European Union: Cannabidiol is Prescription only and OTC in some member states.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 644019, Cannabidiol. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/644019
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Cannabidiol. UNII: 19GBJ60SN5. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/19GBJ60SN5
Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. June 2014; 55(6):791–802. PMID 24854329. https://doi.org/10.1111/epi.12631
Epidiolex – cannabidiol solution. DailyMed. August 26, 2020. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bf27097-4870-43fb-94f0-f3d0871d1eec
Sativex (Cannabidiol/Tetrahydrocannabinol) Bayer Label. bayer.ca. https://omr.bayer.ca/omr/online/sativex-pm-en.pdf
Schedules of Controlled Substances: Placement in Schedule V of Certain FDA-Approved Drugs Containing Cannabidiol; Corresponding Change to Permit Requirements. Federal Register, US Federal Government. September 28, 2018. https://www.federalregister.gov/documents/2018/09/28/2018-21121/schedules-of-controlled-substances-placement-in-schedule-v-of-certain-fda-approved-drugs-containing
RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
DEA announces steps necessary to improve access to marijuana research. DEA. August 26, 2019. https://www.dea.gov/press-releases/2019/08/26/dea-announces-steps-necessary-improve-access-marijuana-research
Laurence E. Your Guide To CBD Legalization By State. Forbes Health. May 31, 2022. https://www.forbes.com/health/cbd/cbd-legalization-by-state/
Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls. Office of Public Affairs. 23 April 2026. https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 14:31:11 |
| drugspro | ok | 2026-11-20 14:31:07 |
| erowid | ok | 2026-11-20 14:31:10 |
| gsrs | ok | 2026-11-20 14:31:08 |
| hmdb | missing (no HMDB id) | 2026-11-20 14:31:07 |
| kegg | ok | 2026-11-20 14:31:09 |
| pubchem | ok | 2026-11-20 14:31:07 |
| ok | 2026-11-20 14:31:07 | |
| sider | missing (not in SIDER) | 2026-11-20 14:31:07 |
| structure | ok | 2026-11-20 14:31:07 |
| wikipedia | ok | 2026-11-20 14:31:07 |